From RCM Leakage To Revenue Growth Engine: The “Multi-Payer Playbook” With Coleman Health Services is starting in

Addiction Treatment Services

Addiction is a chronic disease, which causes individuals to seek “reward” from substance-use or other activities whether or not they may cause harm. Addiction treatment has been in the spotlight as payers, policymakers, and health systems struggle to address the opioid crisis and increasing substance-related mortality rates. As a result, the addiction treatment market is shifting—there is expanded coverage for residential treatment, a push towards greater integration and care coordination, and new competitors entering the market—creating new challenges and opportunities for organizations working in addiction treatment.


Buprenorphine treatment for opioid use disorder (OUD) plus standard medical medication management counseling was as effective as treatment with buprenorphine plus intensive behavioral therapy, a recent study found. Effectiveness was defined as treatment retention and opioid-free weeks over a 12-week period. Those who received buprenorphine with medical management counseling had an average of 7.00 opioid-free weeks, and they stayed in treatment for an average of 10.21 weeks out of a maximum of 12 weeks. Comparatively,… Read